Chris D. Crowder

Ionis Pharmaceuticals (United States)

Papers

2

Total Citations

131

H-Index

2

About

Chris D. Crowder is a leading researcher in vector-borne disease surveillance, with a primary focus on the molecular detection of pathogens transmitted by ticks. His most cited work, "Extraction of Total Nucleic Acids From Ticks for the Detection of Bacterial and Viral Pathogens" (2010), has garnered over 130 combined citations, underscoring its foundational impact on the field. Crowder’s major contribution lies in developing robust, nucleic-acid-based extraction methods that enable simultaneous detection of diverse pathogens—including bacteria and viruses—from a single tick sample. This innovation has significantly advanced active surveillance programs, allowing researchers to more accurately map the frequency and distribution of tick-borne diseases that threaten human and animal health. By streamlining pathogen detection, Crowder’s work has improved early warning systems for outbreaks of infections such as Lyme disease and anaplasmosis. His research is essential for epidemiologists and public health officials working to mitigate the growing burden of vector-borne illnesses. Through these methodological advances, Crowder has established himself as a key figure in the fight against emerging infectious diseases.

Research Focus

Key Achievements

2
H-Index
2
Papers
131
Total Citations
66
Avg Citations/Paper
🏆 Most Cited Paper
Extraction of Total Nucleic Acids From Ticks for the Detection of Bacterial and Viral Pathogens
72 citations · 2010
📈 Most Prolific Year: 2010 (2 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Ionis Pharmaceuticals (United States)

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago